Ascletis Pharma Inc. (OTCMKTS:ASCLF – Get Free Report)’s share price fell 0.8% during trading on Tuesday . The company traded as low as $1.94 and last traded at $1.94. 300 shares were traded during mid-day trading, a decline of 92% from the average session volume of 3,700 shares. The stock had previously closed at $1.9550.
Ascletis Pharma Stock Performance
The firm’s 50 day simple moving average is $1.84 and its 200-day simple moving average is $1.65.
About Ascletis Pharma
Ascletis Pharma (OTCMKTS:ASCLF) is a clinical‐stage biopharmaceutical company headquartered in Hangzhou, China, dedicated to the research, development and commercialization of therapies for viral and liver diseases. Since its founding in 2013, the company has built an integrated platform spanning small‐molecule discovery, process chemistry and clinical development. Ascletis is listed on the Hong Kong Stock Exchange and maintains facilities for both clinical research and commercial manufacturing in Mainland China.
The company’s core pipeline focuses on direct‐acting antiviral agents targeting hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV).
Featured Articles
- Five stocks we like better than Ascletis Pharma
- The gold chart Wall Street is terrified of…
- Iran Conflict Reveals Trump’s Most Powerful Weapon
- Gold’s Next Surge is Imminent
- What a Former CIA Agent Knows About the Coming Collapse
- Read this or regret it forever
Receive News & Ratings for Ascletis Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ascletis Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
